Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.44 |
| ▸ | PTPRB | P23467 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14890680 | 0.93 | TSHR (0.48) | TSHRCYP4F2CYP4A11PTPRBLMNA | |
| SCHEMBL28625986 | 0.88 | TSHR (0.48) | TSHRCYP4F2CYP4A11PTPRBLMNA | |
| SCHEMBL11215497 | 0.82 | CYP4F2 (0.46) | TSHRCYP4F2CYP4A11 | |
| SCHEMBL28936386 | 0.82 | CYP4F2 (0.48) | CYP4F2CYP4A11LMNAALDH1A1CA12 | |
| SCHEMBL7438044 | 0.80 | CYP4F2 (0.67) | CYP4F2CYP4A11LMNAALDH1A1MEN1 | |
| SCHEMBL20002145 | 0.79 | TSHR (0.43) | TSHRCYP4F2CYP4A11LMNAALDH1A1 | |
| SCHEMBL9620419 | 0.78 | TSHR (0.54) | TSHRPTPRBLMNAALDH1A1RECQL | |
| SCHEMBL9245427 | 0.78 | CYP4F2 (0.50) | CYP4F2CYP4A11LMNAMEN1KMT2A | |
| SCHEMBL7438928 | 0.78 | CYP4F2 (0.46) | CYP4F2CYP4A11LMNAKDM4E | |
| SCHEMBL17617116 | 0.77 | CYP4F2 (0.42) | TSHRCYP4F2CYP4A11LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3252861-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME | MITSUBISHI CHEM CORP (JP) | 2019-06-26 | — | — | EP | disclosed |
| WO-2019110355-A1 | BRANCHED ADIPIC ACID BASED ESTERS AS NOVEL BASE STOCKS AND LUBRICANTS | BASF SE (DE) | 2019-06-13 | — | — | WO | disclosed |
| EP-3252861-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| EP-2909285-A1 | GELLING AGENTS AND METHODS OF USING THE SAME | Halliburton Energy Services, Inc. (US) | 2015-08-26 | — | — | EP | disclosed |
| WO-2014062493-A1 | GELLING AGENTS AND METHODS OF USING THE SAME | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-04-24 | — | — | WO | disclosed |
| US-20140110115-A1 | Gelling Agents and Methods of Using the Same | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-04-24 | — | — | US | disclosed |
| EP-2502971-A1 | Modification of Solid Polysaccharide with Transesterification Agent | Halliburton Energy Service, Inc. (US) | 2012-09-26 | — | — | EP | disclosed |
| WO-2012052716-A1 | MODIFICATION OF SOLID POLYSACCHARIDE WITH TRANSESTERIFICATION AGENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20120090846-A1 | MODIFICATION OF SOLID POLYSACCHARIDE WITH TRANSESTERIFICATION AGENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-20120090848-A1 | MODIFICATION OF SOLID POLYSACCHARIDE WITH TRANSESTERIFICATION AGENT | HALLIBURTON ENERGY SERVICES, INC. | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | KCNN2, KCNE1, KCNN1 | TSHR 3439/4885CYP4F2 3581/4885CYP4A11 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.